Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
About this item
Full title
Author / Creator
Liu, Ying , Jin, Xiu , Gong, Yingying , Ma, Yingying , Du, Beibei , Yang, Linqing , Wang, Yunfei and Zhu, Weipei
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
This study aimed to assess the value of an HPV E6/E7 mRNA assay and HPV 16 18/45 genotype assay combined with age stratification for triaging women negative for intraepithelial lesions or malignancy (NILM) cytology.
From January 2017 to December 2021, a total of 162,309 eligible women underwent cervical cancer screening at the Affiliated Hospita...
Alternative Titles
Full title
Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_298de438055f4963b091cc610e023af6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_298de438055f4963b091cc610e023af6
Other Identifiers
ISSN
1750-9378
E-ISSN
1750-9378
DOI
10.1186/s13027-023-00531-w
